Caitlin says: ” Doctors need to know to give adequate care, and ask the right questions to assess breast cancer risk in their patients, and being a DES daughter is a big one… more funds are needed for better studies…”.
Widespread Failure among Doctors to follow Clinical Guidelines
A report out this week, submitted to a medical journal but not yet published, discusses the findings of a study analysing the treatment and results of 13,321 women with ovarian cancer diagnosed from 1999 to 2006 in California. Only 37 percent received treatment that adhered to guidelines set by the National Comprehensive Cancer Network…
How Drug Companies Mislead Doctors and Harm Patients
Last February 18th, 2013, at Town Hall Seattle, Dr. Ben Goldacre talked about his book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, in which he discusses the influence of the pharmaceutical industry on the global healthcare system and argues that pharmaceutical companies hide negative studies and use questionable testing and intensive lobbying to get what they want, regardless of whether the drugs they produce are good for patients. Watch the video (1 hour, 26 minutes) .
Why do so many doctors still think they are invincible to Big Pharma’s influence?
” The bottom line for any for-profit company is to sell their product, and since the pharmaceutical industry can’t sell drugs directly to patients, they convince doctors to prescribe them. The more a doctor sees or hears the name of a drug, whether through drug reps, brochures or seeing the name on stationery, the more likely the drug is to be prescribed. ”
Can you understand your doctor’s handwriting? For DES daughters, finding medical records showing that their mums were prescribed DES during pregnancy can be very difficult. If the doctor has retired or died, another doctor may have taken over the practice as well as the records or if the records are found they may just be unreadable …!
How Drug Companies mislead Doctors and harm Patients
When a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
The video, shot during the debate at the Royal Institution last month, shows the author of Bad Science and Bad Pharma debate the notion ‘Pharma is not getting its act together’ with the chief executive of the ABPI.
Doctors, not drugmakers, must warn patients of risks, court says
” The Supreme Court of Texas has ruled that pharmaceutical manufacturers are not responsible for conveying drug risks to patients, even when the drugmakers advertise their products directly to consumers… Health professionals said the decision creates greater liability for doctors and removes necessary responsibility from drugmakers after medication mishaps… drugmakers are not completely without liability if a patient is injured by a drug. If incorrect information is passed to physicians, a manufacturer still can be held liable… But drug companies cannot be sued for failing to provide drug warning information directly to a patient…” .